Cardiorespiratory Effects of Nasal High Frequency Ventilation in Neonates
Ventilator Lung; Newborn, Hemodynamic Instability, Echocardiography
About this trial
This is an interventional treatment trial for Ventilator Lung; Newborn focused on measuring Premature infants, Echocardiography
Eligibility Criteria
Inclusion Criteria: Moderate and late preterm infants born between 32+0 to 36+6 weeks gestation(according to WHO definitions of preterm birth) admitted to the neonatal intensive care unit with spontaneous breathing and clinical manifestations of RD (tachypnea, nasal flaring, intercostal and subcostal retraction and or grunting). Exclusion criteria: Any baby intubated for resuscitation or for other reasons. Obvious major congenital malformations or known complex congenital heart disease. Pulmonary hemorrhage. Cardiopulmonary arrest needing prolonged resuscitation.
Sites / Locations
- Neonatal Intensive Care Unit (NICU) of Alexandria University Maternity Hospital.
Arms of the Study
Arm 1
Arm 2
Active Comparator
Placebo Comparator
Group I
Group II
Nasal high-frequency ventilation (NHFV) group (case group):
Nasal CPAP group (control group):